SACRAMENTO, Calif., Nov. 16 /PRNewswire/ -- InVitria(TM), a global supplier of animal-free products for use in bioprocessing, research and diagnostics, today announced Victor Hicks would be joining the company as Commercial Director.
Hicks, an accomplished sales executive with more than 25 years of experience in the bioprocessing industry, will lead InVitria’s commercial activities including sales and marketing. Prior to joining InVitria, he was Business Development Manager at Millipore Corporation, a biopharmaceutical manufacturing supplier. Victor has also held commercial leadership positions with Serologicals, Becton-Dickinson Company, JRH Biosciences, Difco Laboratories, and the 3M Company.
“I am excited about the opportunity to join the InVitria team,” said Hicks. “The InVitria product line will provide customers with what they have been requesting -- animal-free media supplements that provide optimum performance.”
InVitria’s product portfolio consists of the following products: -- Lacromin(TM) (recombinant human lactoferrin) is a growth factor for cell culture media that improves productivity and safety. Lacromin has been shown to outperform bovine or human transferrin, a common animal-derived growth factor and source of iron. -- Lysobac(TM) (recombinant human lysozyme) is a bacterial cell lysis agent and can be used in diagnostic applications, bioprocessing and life science research. Lysobac is a powerful cell lysis agent that outperforms chicken lysozyme, a common animal-derived cell lysis agent. -- Cellastim(TM) (recombinant human serum albumin) is an essential cell culture media component for use in a variety of applications including mammalian cell culture to replace human and bovine serum albumin and fetal bovine serum for animal-free cell culture media. For more information, please visit our website at http://www.InVitria.com Or contact: info@InVitria.com 1-800-916-8311
Statements in this announcement other than historical data and information constitute forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from those stated or implied by such forward-looking statements. Potential risks and uncertainties may include, but are not limited to, recent changes in senior management, fluctuations in operating results, market conditions and changes in technology and increased competition.
InVitria
CONTACT: Brandy Sargent of InVitria, 1-800-916-8311, or info@InVitria.com
Web site: http://www.InVitria.com//
